Advertisement

Digestive Diseases and Sciences

, Volume 45, Issue 10, pp 1929–1934 | Cite as

Fatty Infiltration of Liver in Hyperlipidemic Patients

  • Nimer Assy
  • Kelly Kaita
  • David Mymin
  • Clifford Levy
  • Barry Rosser
  • Gerald Minuk
Article

Abstract

Hyperlipidemia is a known risk factor for fatty infiltration of the liver, a condition that can progress to cirrhosis and liver failure. The objectives of this study were to document the prevalence of fatty infiltration in the livers of hyperlipidemic patients and to identify the predictor variables associated with this condition. Over an 18-month recruitment period, clinical, biochemical, and radiologic assessments were performed in a cross-sectional manner in 95 adult patients referred to an urban hospital-based lipid clinic for evaluation and management of hyperlipidemia. The mean (±sd) age of the patients was 55 ± 13 years. Forty-eight (51%) were male. Fifty-two patients (55%) had hypercholesterolemia, 25 (26%) severe hypertriglyceridemia, 14 (15%) mixed hyperlipidemia, and 4 (4%) moderate hypertriglyceridemia. Obesity and diabetes were present in 36 (38%) and 12 (12%) of cases, respectively. A total of 61 (64%) patients had elevated liver enzyme tests. The most common enzyme abnormalities were an elevated serum ALT in 45 (47%) and GGT in 43 (45%) of patients. Ultrasound findings revealed diffuse fatty liver in 47 patients (50%), of which 21 cases (22%) were mild, 18 (19%) moderate, and 8 (9%) severe. The majority of patients with hypercholesterolemia [35/52 (67%)] had normal ultrasounds, whereas severe hypertriglyceridemia and mixed hyperlipidemia were frequently associated with radiologic evidence of fatty liver (odds ratios 5.9 and 5.1 respectively, P < 0.01). Independent predictors of fatty liver were; AST (P = 0.001), hyperglycemia (P = 0.02), and age (P = 0.04). In a model incorporating known risk factors for fatty liver, diabetes was the only risk factor other than hypertriglyceridemia that was significantly associated with fatty infiltration. No such effect was seen with age, gender, obesity, or alcohol consumption. In conclusions, the results of this study indicate that ultrasonographic evidence of fatty infiltration of the liver is evident in approximately 50% of patients with hyperlipidemia. Hypertriglyceridemia is the lipid profile most often associated with this condition. Serum AST values, hyperglycemia, and age independently predict the presence of fatty infiltration, while hypertriglyceridemia and diabetes are the only risk factors that significantly increase the risk of fatty infiltration in hyperlipidemic patients.

hyperlipidemia nonalcoholic hepatosteatonecrosis lipid hepatitis fatty liver ultrasound 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Alpers DH, Sabesin SM, White HM: Fatty liver: biochemical and clinical aspects. In Disease of the Liver, 7th ed. L Schiff and ER Schiff (eds). Philadelphia, JB Lippincott, 1993, pp 825-855Google Scholar
  2. 2.
    Ludwig J, Viggiano TR, McGill DB, Ott BJ: Nonalcoholic steatohepatitis. Mayo clinical experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434-438, 1980Google Scholar
  3. 3.
    Alder M, Schaffner F: Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 67:811-816, 1979Google Scholar
  4. 4.
    Anon: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 148:36-39, 1988Google Scholar
  5. 5.
    Anon: The International Committee for the Evaluation of Hypertriglyceridemia as a Vascular Risk Factor. The hypertriglyceridemias: Risk and management. Am J Cardiol 68:1A-42A, 1991Google Scholar
  6. 6.
    Friedewald WT, Levy RJ, Frederickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preoperative ultracentrifuge. Clin Chem 18:499-502, 1972Google Scholar
  7. 7.
    Marz W, Serkmeier R, Gross W, Kostner GM: Determination of lipoprotein (a): evaluation of three methods. Eur J Clin Chem Clin Biochem 31:295-302, 1993Google Scholar
  8. 8.
    Willey DG, Rosenthal MA, Caldwell S: Glycosylated hemoglobin and plasma glycoprotein assays by affinity chromatography. Diabetologia 27:56-58, 1984Google Scholar
  9. 9.
    Scatarige JC, Scott WE, Donovan PJ, et al: Fatty infiltration of the liver. Ultrasonographic and computed tomographic correlation. J Ultrasound Med 3:9-14, 1984Google Scholar
  10. 10.
    Scott WW, Sanders RC, Siegelman SS: Irregular fatty infiltration of the liver, diagnostic dilemmas. AJR 135:67-71, 1980Google Scholar
  11. 11.
    Williamson DF: Descriptive epidemiology of body weight and change in US adults. Ann Intern Med 119:646-649, 1993Google Scholar
  12. 12.
    O'Hare JA, Weir GC: Insulin therapy. In Principles and Practice of Endocrinology and Metabolism. KL Becker, et al (eds). Philadelphia, JB Lippincott, 1990, pp 1102-1109Google Scholar
  13. 13.
    Saveryumuttu SH, Joseph AEA, Maxwell JD: Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 292:13-15, 1986Google Scholar
  14. 14.
    Hultcrantz R, Gabrielsson N: Patients with persistent elevation of aminotransferases: Investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med 233:7-12, 1993Google Scholar
  15. 15.
    Joseph AEA, Saverymuttu SH, AI-Sam S, Cook MG, Maxwell JD: Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 43:26-31, 1991Google Scholar
  16. 16.
    Layer G, Zuna I, Lorenz A, Zerban H, Haberkorn U, Bannasch P, van Kaick G, Rath U: Computerized ultrasound B-scan texture analysis of experimental diffuse parenchymal liver disease: Correlation with histopathology and tissue composition. J Clin Ultrasound 19:193-201, 1999Google Scholar
  17. 17.
    Cavouras D, Kandarakis I, Theotokas I, Kanellopoulos E, Triantis D, Behrakis I, Manesisi EK, Vafiadi-Zoumpouli I, Zoumpoulis P: Computer image analysis of ultrasound images for discriminating and grading liver parenchyma disease employing a hierarchical decision tree scheme and the multilayer perception neural network classifier. Stud Health Technol Inform 43:522-526, 1997Google Scholar
  18. 18.
    Mendler MH, Bouillet P, Le Sidaner A, Lavoine E, Labrousse F, Sautereau D, Pillegand B: Dual-energy CT in the diagnosis and quantification of fatty liver: Limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 28:785-794, 1998Google Scholar
  19. 19.
    Davies RJ, Saverymuttu SH, Fallowfield M, Joseph AE: Paradoxical lack of ultrasound attenuation with gross fatty change in the liver. Clin Radiol 43:393-396, 1991Google Scholar
  20. 20.
    Ochs A, Rottler RM, Scholmerich J: Clinical relevance of abnormal liver findings with ultrasound. Hepatogastroenterology 41:9-15, 1994Google Scholar
  21. 21.
    Glickman RM, Sabesin SM. Lipoprotein metabolism. In The Liver: Biology and Pathobiology. 3rd ed. IM Arias, JL Boyer, N Fausto, WB Jacoby, DA Schachter, DA Shafritz (eds). New York, Raven Press, 1994, pp 391-414Google Scholar
  22. 22.
    Bengmark S: Liver steatosis and liver resection. Digestion 2:304, 1969Google Scholar
  23. 23.
    Stone BG, Van Thiel TH: Diabetes mellitus and the liver. Semin Liver Dis 5:8-28, 1985Google Scholar
  24. 24.
    Clain DJ, Lefkowitch JH: Fatty liver disease in morbid obesity. Gastroenterol Clin North Am 16:239-252, 1987Google Scholar
  25. 25.
    Bjortorp P: Regional obesity and NIDDM. In New Concepts in the Pathogenesis of NIDDM. CG Ostenson, S Efendic, M Vranic (eds). New York, Plenum Press, 1993, pp 279-285Google Scholar
  26. 26.
    Steiner G. Hyperinsulinaemia and hypertriglyceridemia. J Intern Med 236:23-26, 1994Google Scholar
  27. 27.
    Reaven GM: The role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988Google Scholar
  28. 28.
    Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM: Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 94:2557-2562, 1997Google Scholar
  29. 29.
    Galambos JT, Willis CE: Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology 74:1191-1199, 1978Google Scholar
  30. 30.
    Savolainen VT, Liesto K, Mannikko A, Penttila A, Karhunen PJ: Alcohol consumption and alcoholic liver disease: Evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 17(5):1112-1117, 1993Google Scholar

Copyright information

© Plenum Publishing Corporation 2000

Authors and Affiliations

  • Nimer Assy
    • 1
  • Kelly Kaita
    • 1
  • David Mymin
    • 1
  • Clifford Levy
    • 1
  • Barry Rosser
    • 1
  • Gerald Minuk
    • 1
  1. 1.Liver Diseases Unit and Lipid Clinic, Departments of Medicine and RadiologyUniversity of ManitobaWinnipegCanada

Personalised recommendations